These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 552225)

  • 21. International collaborative studies on potency assays of diphtheria and tetanus toxoids.
    Van Ramshorst JD; Sundaresan TK; Outschoorn AS
    Bull World Health Organ; 1972; 46(2):263-76. PubMed ID: 4537488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potency tests of diphtheria, tetanus and combined vaccines. Suggestion for a simplified potency assay.
    Aggerbeck H; Heron I
    Dev Biol Stand; 1996; 86():297-301. PubMed ID: 8785958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potency assay of diphtheria and tetanus toxoids some theoretical and practical considerations.
    Lyng J
    Dev Biol Stand; 1986; 64():47-50. PubMed ID: 3792657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitation of tetanus and diphtheria antitoxins in mouse sera by indirect haemagglutination.
    Maheshwari SC; Sharma SB; Kumar A; Sokhey J
    J Commun Dis; 1998 Mar; 30(1):23-8. PubMed ID: 9842161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An approach to establishing diphtheria potency specifications for diphtheria and tetanus toxoid, acellular pertussis vaccine formulations linked to clinical efficacy.
    Brock B; Mckee B
    Biologicals; 1999 Jun; 27(2):183. PubMed ID: 10600210
    [No Abstract]   [Full Text] [Related]  

  • 26. A consideration of some methods by which the cost of potency assays for diphtheria and tetanus vaccines might be reduced.
    Knight PA
    Dev Biol Stand; 1978; 41():67-72. PubMed ID: 753671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of reductions in the numbers of animals used for the potency assay of the diphtheria and tetanus components of adsorbed vaccines by the methods of the European pharmacopoeia.
    Hendriksen CF; van der Gun JW; Marsman FR; Kreeftenberg JG
    J Biol Stand; 1987 Oct; 15(4):353-62. PubMed ID: 3680303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of adjuvant effect of the pertussis component on IPV DTP-polio vaccine in children.
    Cadoz M; Montagnon B; Yvonnet B; Xueref C; Vincent-Falquet JC; Bandet R; Gibelin N
    Dev Biol Stand; 1986; 65():153-8. PubMed ID: 2881819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Value of national standards in the control of standardization of diphtheria and tetanus anatoxins. Conditions of measurement in international units and immunogenic value of tetanus anatoxin for guinea pigs and mice].
    Demian L; Lazăr M
    Arch Roum Pathol Exp Microbiol; 1969; 28(2):297-302. PubMed ID: 5400034
    [No Abstract]   [Full Text] [Related]  

  • 30. A collaborative investigation of a potency assay for adsorbed tetanus vaccines based on the protection of mice from tetanic paralysis.
    Mussett MV; Sheffield F
    J Biol Stand; 1976 Apr; 4(2):141-8. PubMed ID: 932045
    [No Abstract]   [Full Text] [Related]  

  • 31. Letter: Triple vaccine.
    Indian Pediatr; 1974 Nov; 11(11):763-4. PubMed ID: 4443052
    [No Abstract]   [Full Text] [Related]  

  • 32. An evaluation of some proposals for a reduction in the number of animals used for the potency testing of diphtheria and tetanus vaccines.
    Knight PA; Roberts PA
    J Biol Stand; 1987 Apr; 15(2):165-75. PubMed ID: 3597449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of combined diphtheria, tetanus and pertussis vaccines produced by different manufacturers, in laboratory animals and in infants.
    Nyerges G; Adám MM; Gács P; Ring R
    J Biol Stand; 1986 Jul; 14(3):241-7. PubMed ID: 3489716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous administration of diphtheria/tetanus/pertussis/polio vaccine and hepatitis B vaccine in a simplified immunization programme.
    Coursaget P; Yvonnet B; Relyveld EH; Barres JL; Diop-Mar I; Chiron JP
    Dev Biol Stand; 1986; 65():169-75. PubMed ID: 2881821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
    Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of a guinea pig model to assess interference in the immunogenicity of different components of a combination vaccine comprising diphtheria, tetanus and acellular pertussis (DTaP) vaccine and haemophilus influenzae type b capsular polysaccharide conjugate vaccine.
    Gupta RK; Anderson R; Cecchini D; Rost B; Xu J; Gendreau K; Saroff DL; Marchant C; Siber GR
    Biologicals; 1999 Jun; 27(2):167-76. PubMed ID: 10600208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consistency testing of diphtheria and tetanus to replace potency testing for lot release.
    Kreeftenberg JG
    Dev Biol (Basel); 2002; 111():291-8. PubMed ID: 12678252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of the vaccines used in the prevention of bacterial diseases in children in Argentina during 1980-1986.
    Dellepiane NI; Spizzamiglio G
    Ann Sclavo Collana Monogr; 1986; 3(1-2):353-8. PubMed ID: 3501299
    [No Abstract]   [Full Text] [Related]  

  • 39. Are potency tests for tetanus vaccines really necessary?
    Knight PA
    Dev Biol Stand; 1986; 64():39-45. PubMed ID: 3792656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Half-dose immunization for diphtheria, tetanus, pertussis: response of preterm infants.
    Bernbaum J; Daft A; Samuelson J; Polin RA
    Pediatrics; 1989 Apr; 83(4):471-6. PubMed ID: 2538797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.